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Cycler adequacy and prescription data in a national cohort Peritoneal dialysis (PD) remains a small but important
sample: The 1997 core indicators report. renal replacement modality in the United States. Among
Background. The Health Care Financing Administration all patients receiving dialytic therapy for their end-stagePeritoneal Dialysis Core Indicator Project obtains data yearly
renal disease (ESRD) in the United States, less than 20%in four areas of patient care: dialysis adequacy, anemia, blood
pressure, and nutrition. receive some type of PD. The percentage of patients re-
Methods. Adequacy and dialysis prescription data were ob- ceiving PD between the years 1986 and 1995 has remained
tained using a standardized data abstraction form from a ran- relatively unchanged [1, 2]. The explanation for PD’s fail-dom sample of adult U.S. peritoneal dialysis patients who were
ure to increase in importance appears related to its inabil-alive on December 31, 1996.
ity to retain patients [1–5]. The incidence of newly trainedResults. For the cohort receiving cycler dialysis, 22% were
unable to meet the National Kidney Foundation Dialysis Out- PD patients remains high (approximately 20% of all new
come Quality Initiatives (NKF-DOQI) dialysis adequacy guide- dialysis patients) [1, 2], and the transplantation and mor-
lines because they did not have at least one adequacy measure
tality rates of PD patients are generally similar to thoseduring the six-month period of observation. Thirty-six percent
of a matched hemodialysis population [1, 2]. Thus, anof patients met NKF-DOQI guidelines for weekly Kt/V urea,
33% met guidelines for weekly creatinine clearance (CCr), and excessive transfer of continuous ambulatory PD (CAPD)
24% met guidelines for both urea and creatinine clearances. patients to center hemodialysis probably accounts for
The mean weekly adequacy values were 2.24 6 0.56 for Kt/V
the stagnant size of the PD population. The reasons forurea and 67.5 6 24.4 liter/1.73 m2 for CCr, and the median
these transfers are not fully characterized, although thevalues were 2.20 and 62.25 liter/1.73 m2, respectively. The mean
prescribed 24-hour volume was 12,040 6 3255 ml, and the following hypotheses have evoked substantial support:
median prescribed volume was 11,783 ml. Only 60% of patients frequent peritonitis, recurrent catheter infection, inordi-
were prescribed at least one daytime dwell. By logistic regres- nate stress with resulting psychosocial adjustment prob-sion analysis, risk factors for an inadequate dose of dialysis
lems, peritoneal membrane failure, poor patient com-included being in the highest quartile of body surface area
(odds ratio 5 3.3 for CCr and 3.4 for Kt/V urea) and a duration pliance, patient “burn out,” and a belief that present
of dialysis greater than two years (odds ratio 5 4.2 for CCr and prescription practices favor excess morbidity [2–7].
2.1 for Kt/V urea). Although the percentage of ESRD patients receivingConclusion. There is much room for improvement in provid-
PD has not changed significantly over the past five years,ing an adequate dose of dialysis to cycler patients. Practitioners
the type of PD performed has changed dramatically inshould be more aggressive in increasing dwell volumes, adding
daytime dwells, and adjusting nighttime dwell times in order the past three years. An increasing percentage of patients
to compensate for the loss of residual renal function over time. now use some form of cycler therapy for PD. The U.S.These changes can only be accomplished if practitioners mea-
Renal Data System reports that the percentage of PDsure periodically the dose of dialysis as outlined in the NKF-
patients using cycler therapy has increased from 15% inDOQI guidelines.
1995 to more than 22% in 1996 [2]. This increase in cycler
use appears to have coincided with the introduction ofKey words: cycler dialysis, peritoneal dialysis, Kt/V urea, creatinine
clearance, dialysis adequacy, NKF-DOQI guidelines. several new devices that appear to simplify the PD regi-
men for cycler patients.Received for publication July 16, 1998
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ministration Peritoneal Dialysis Core Indicators Study formed by standard methods using data from 24-hour
dialysate and urine collections. Creatinine values were(HCFA PD-CIS) is a cross-sectional prevalence survey
describing the U.S. PD population and several outcome not corrected for potential interference by glucose, and
no attempt was made to determine the timing of theindicators on an annual basis [8]. Because there are sub-
stantial regional variations in the percentage of patients serum samples used for adequacy measures. For Kt/V
urea, residual renal function was calculated using urineusing PD and because both patient characteristics and
dialysis methods influence treatment results, this report urea clearance only. For creatinine clearance, residual
renal function was calculated to be the average of thedescribes a representative national sample for compara-
tive assessment. An earlier survey (1995 PD-CIS) re- urine urea and creatinine clearances. The volume was
determined by the method of Watson [10], and the bodyvealed that anemia treatment practices were relatively
uniform across the United States, but detected substan- surface area was calculated using the formula by duBois
and duBois [11].tial variability in PD prescription practices and the mea-
surement of PD “adequacy” [9]. This manuscript reviews Data analyses were performed using Epi Info version
6.04 [12] and SPSS for Windows version 6.1 [13]. Analyticthe data collected for the 1997 survey and investigates
the hypothesis that dialysis prescriptions are altered to methods included the calculation of descriptive parame-
ters, including percentiles for distributions in which thesustain minimal “adequacy” standards.
mean and median values differed. Comparative testing
used the two-tailed Student’s t-test assuming equal vari-
METHODS
ances and chi-square analyses. A two-tailed P value of
A stratified random sample of 1375 adult (age 18 years less than 0.05 was considered significant. Logistic regres-
or more) PD patients alive on December 31, 1996 (ap- sion analyses were conducted to determine significant
proximately 5% of the adult PD population stratified predictors for calculated weekly Kt/V urea and creati-
by ESRD Network), was identified by the HCFA for nine clearance below those recommended by the Na-
inclusion in the 1997 PD-CIS cohort. Analysis was re- tional Kidney Foundation Dialysis Outcome Quality Ini-
stricted to patients who had not received hemodialysis tiatives (NKF-DOQI) guidelines [14]. These DOQI
during the study period but who had been on PD during guidelines include a weekly Kt/V urea of at least 2.1 and
part or all of the six-month reporting interval. a creatinine clearance of at least 63 liter/week/1.73 m2
In July 1997, regional ESRD networks mailed stan- for CCPD patients and a weekly Kt/V urea of at least
dardized questionnaires to the dialysis providers serving 2.2 and a creatinine clearance of at least 66 liter/week/
each selected patient. The data abstraction form re- 1.73 m2 for nocturnal intermittent peritoneal dialysis
quested information on patient demographics, primary (NIPD) patients. A backward stepwise regression proce-
diagnosis, and laboratory and clinical parameters for dure was employed to obtain the final model. Only pre-
each two-month interval during the six-month survey dictors with a P value of less than 0.05 were retained in
(November through December 1996, January through the final model.
February 1997, and March through April 1997). Dialysis
unit personnel were instructed to obtain the medical
RESULTScharts for each sampled patient and to record all of the
Response ratetreatment modalities used by the patient (CAPD, cycler,
or hemodialysis), and for each two-month period the The response rate for the 1997 PD survey was 89%.
first available entry for serum albumin level (including Of the 1219 patients for whom data were received, 521
the laboratory method used to determine these results); (43%) received cycler PD for all or part of the six-month
hematocrit; systolic and diastolic blood pressure; 24-hour period of observation. The demographic characteristics
dialysate for volume, urea and creatinine; 24-hour urine of the cycler versus the CAPD cohort are depicted in
for volume, urea and creatinine; calculated weekly Kt/V Table 1; there were no significant demographic differ-
urea and creatinine clearance [including the method by ences between CAPD and cycler patients.
which volume (V) and body surface area (BSA) were
Measurement of dialysis adequacydetermined]; plasma urea and creatinine; and patient
weight and height. Completed forms were returned to Peritoneal dialysis adequacy was assessed by two dif-
their respective ESRD network office for data confirma- ferent methods. First, the survey obtained raw data that
tion and computer entry. These data were then for- allowed for the calculation of weekly Kt/V urea and
warded to the HCFA for aggregation and analysis. creatinine clearances. Second, the survey asked for the
Measures of dialysis adequacy were obtained using weekly Kt/V urea and creatinine clearance values calcu-
both reported values provided by individual dialysis cen- lated by either the dialysis center or the center’s clinical
ters and values calculated from raw data. The calculation laboratory. For the cycler cohort, a weekly Kt/V urea
was calculated from raw data in 69% of patients, forof weekly Kt/V urea and creatinine clearances was per-
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Table 1. Characteristics of adult ($18 years) peritoneal patients in and 4 demonstrate the relationship between adequacy
the ESRD Core Indicators Study, 1997
of dialysis and both duration of dialysis (a surrogate for
CAPD Cycler patients residual renal function) and body size. Note that for
Total [N (%)] 757 (100) 521 (100) weekly Kt/V urea adequacy measures declined as either
duration of dialysis or BSA increased. A similar but lessGender [N (%)]
Males 378 (50) 279 (54) consistent pattern was seen regarding weekly creatinine
Females 379 (50) 242 (46) clearances.Race [N (%)]
Table 2 depicts the risk factors associated with anAfrican American 201 (27) 116 (22)
Caucasian 477 (63) 357 (69) increased likelihood of receiving inadequate dialysis ac-
Other/unknown 79 (10) 48 (9) cording to DOQI guidelines. For Kt/V urea, males andAge group years [N (%)]
patients in the 25th to highest BSA quartile were at in-18–44 192 (25) 140 (27)
45–64 362 (48) 228 (44) creased risk of receiving inadequate dialysis in compari-
651 203 (27) 153 (29) son to females and patients in the lowest BSA quartile.Primary diagnosis [N (%)]
By logistic regression analysis, among patient character-Diabetes mellitus 260 (34) 179 (34)
Hypertension 166 (22) 114 (22) istics examined (Table 3), only duration of dialysis greater
Glomerulonephritis 142 (19) 89 (17) than two years, being in the 25th to 50th BSA quartile orOther/unknown 189 (25) 139 (27)
highest quartile of BSA and male gender were significantBSA mean 6 sd, m2 1.8560.25 1.8460.25
Median 1.85 1.80 predictors for having calculated weekly Kt/V urea values
Duration of dialysis below that recommended by DOQI guidelines. ForMean 6 sd, years 2.7663.4 2.5263.1
weekly creatinine clearance, females and patients on di-Median, years 1.70 1.50
alysis for more than one year were at increased risk ofP value , 0.01 for comparison between CAPD and cycler patients
receiving inadequate dialysis in comparison to males and
patients on dialysis for less than one year. By logistic
regression analysis, being on dialysis for more than two
weekly creatinine clearance in 68% of patients, and for years, being in the 25th to 50th BSA quartile or highest
both Kt/V urea and creatinine clearance in 64% of pa- quartile of BSA and female gender remained as signifi-
tients. Reported values were available for approximately cant predictors for having weekly calculated creatinine
one third of patients who did not have a calculated ade- clearance values below that recommended by DOQI
quacy value. In total, using either calculated or reported guidelines.
values, adequacy values were available during the six- Dialysis adequacy in cycler patients can be improved
month period of observation for 76% of patients for by increasing the nighttime dwell volume, optimizing
weekly Kt/V urea, 74% for creatinine clearance, and the number and/or length of nighttime exchanges, or by
72% for both adequacy values. increasing the number of daytime exchanges. The mean
prescribed 24-hour volume was 12,040 6 3255 ml, and
Dialysis adequacy values the median prescribed volume was 11,783 ml. Figure 5
The mean calculated weekly Kt/V urea and creatinine depicts the relationship between the prescribed daily
clearances in the cycler cohort were 2.24 6 0.56 and dialysate volume and both body size and duration of
67.45 6 24.4 liter/1.73 m2, respectively, and the median dialysis, the latter a surrogate of residual renal function.
values were 2.20 and 62.25, respectively. Histograms de- Although the average prescribed volume in cycler pa-
picting the distribution of these values are shown in Fig- tients increased from 11,778 ml in patients dialyzed for
ures 1 and 2. Twenty-two percent of the entire cohort less than two years to 12,446 ml in patients dialyzed for
were unable to meet NKF-DOQI guidelines, as they did greater than two years, the calculated weekly Kt/V urea
not have at least one adequacy measure during the six- declined from 2.31 6 0.53 in patients with a duration of
month period of observation. Only 36% of all patients dialysis less than one year to 2.15 6 0.54 in patients
surveyed met NKF-DOQI guidelines for weekly Kt/V with a duration of dialysis greater than two years. The
urea. Thirty-three percent met guidelines for weekly cre- calculated weekly creatinine clearance declined from
atinine clearance, and 24% met guidelines for both Kt/V 75 6 29 liter/week/1.73 m2 in patients with a duration of
urea and creatinine clearance. Therefore, a significant dialysis less than one year to 60 6 17 liter/week/1.73 m2
proportion of cycler patients were receiving inadequate in patients with a duration of dialysis greater than two
dialysis as defined by NKF-DOQI guidelines. If only the years. Therefore, although the dialysis prescription is
approximately three quarters of patients with at least one adjusted to account for the decline in residual renal func-
adequacy measure were analyzed, then 48% of cycler tion, the adjustment is still not sufficient to prevent, on
patients met guidelines for Kt/V urea; 44% met guide- average, a decline in the dose of dialysis provided.
lines for creatinine clearance, and 32% met guidelines One of the most effective methods for increasing dial-
ysis adequacy is to increase dwell volumes. Although thefor both Kt/V urea and creatinine clearance. Figures 3
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Fig. 1. Distribution of the calculated weekly Kt/V urea values in the 1997 peritoneal dialysis (PD) cycler cohort.
Fig. 2. Distribution of the calculated weekly
creatinine clearance values in the 1997 PD
cycler cohort.
average PD cycler patient has a BSA of 1.84 6 0.25 m2, dialysis are shown in Table 4. For patients on dialysis
for greater than two years (presumably with negligiblethe median nighttime and daytime dwell volumes were
only 2000 ml. The distribution of nighttime and daytime residual renal function), the average dwell volumes were
2219 6 368 ml at night and 1952 6 493 ml during thedwell volumes is depicted in Figure 6. For nighttime
dwell volumes, 39.8% of patients had 2000 ml dwell day. An analysis of the appropriateness of nighttime
dwell times is more difficult to perform because the opti-volumes; 22.7% had 2500 ml dwell volumes, and 15.7%
had dwell volumes between 2000 and 2500 ml. Note mal dwell time will be dependent on peritoneal transport
characteristics. The distribution of nighttime dwell timesthat, on average, daytime dwell volumes were lower than
nighttime dwell volumes. The distributions of nighttime is shown in Figure 7. Daytime dwell times were uniformly
distributed between 240 and 960 minutes. The distribu-and daytime dwell volumes by BSA and duration of
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Fig. 3. Relationship between calculated weekly Kt/V
urea, body surface area, and duration of dialysis.
Fig. 4. Relationship between calculated weekly creatinine
clearance, body surface area, and duration of dialysis.
tion of the number of daytime and nighttime exchanges in early 1997, prior to the dissemination of the NKF-
DOQI guidelines for dialysis adequacy. Only 32% of allis shown in Figure 8. Only 60% of cycler patients were
patients for whom adequacy measures were availableprescribed at least one daytime dwell, and the vast major-
met NKF-DOQI guidelines for both weekly Kt/V ureaity of patients received only one daytime dwell. Within
and creatinine clearance.each sector of a matrix consisting of duration of dialysis
Although the adequacy guidelines for cycler therapyand body size, patients receiving inadequate dialysis
are opinion based, theoretical analysis supports the rec-were more likely not to have a daytime dwell than pa-
ommendation that cycler adequacy levels should be highertients receiving adequate dialysis.
than the evidence-based CAPD adequacy guidelines
[15]. We have demonstrated that the risk of inadequate
DISCUSSION dialysis increases with longer duration of dialysis (a sur-
This is the first report of dialysis adequacy in a large, rogate for loss of residual renal function) and higher
national prevalent sample of PD cycler patients in the body surface area. The observation that males were at
United States. Our data demonstrate that a large propor- increased risk of inadequate dialysis as measured by Kt/V
and that females were at increased risk of inadequatetion of cycler patients received less than adequate dialysis
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Table 2. Mean calculated weekly Kt/V urea and creatinine clearance values in 1997 PD-CIS cycler patients
Kt/V urea Creatinine clearancea
Percent meeting
% meeting % meeting DOQI guidelines
DOQI DOQI for both Kt/V
Mean guidelinesb Mean guidelines and CCr
Total 2.2460.56 36 67.45624.4 33 24
Gender
Males 2.0860.50e 27e 70.52625.4d 38d 25
Females 2.4260.56 47 63.74622.6 26 24
Race
African American 2.1660.58 31 63.96623.8 27 20
Caucasian 2.2560.54 38 68.72624.8 35 25
Other/unknown 2.2660.63 39 62.88619.3 26 24
Age group years
18–34 2.2760.62 36 70.28626.6 36 27
45–64 2.2460.58 37 66.36623.7 33 25
651 2.2060.45 37 66.51623.3 29 22
Primary diagnosis
Diabetes mellitus 2.3060.55 38 71.14627.3 36 26
Hypertension 2.2160.54 38 65.48620.0 25 19
Glomerulonephritis 2.2560.64 32 63.30622.3 36 27
Other/unknown 2.1760.51 34 67.50624.9 32 24
Years on dialysis
,1 2.3160.53 41 74.98629.0e 43e 32d
1–2 2.2660.63 35 67.92622.8 33 24
21 2.1560.54 32 59.57616.5 22 17
Quartile BSA (m2)
,25th percentile–low 2.5360.63e 55e 70.03625.8 37 34c
25th-50th percentile 2.2160.50 36 63.12619.4 32 20
50th-75th percentile 2.1960.45 47 69.60622.0 47 34
.75th percentile–high 2.0360.53 29 66.69628.7 34 24
a liter/week/1.73 m2
b DOQI guidelines: For cycler patients with daytime dwell: Kt/V urea $ 2.1, creatinine clearance $ 63 liter/week/1.73 m2. For cycler patients without a daytime
dwell: Kt/V urea $ 2.2, creatinine clearance $ 66 liter/week/1.73 m2
Statistically significant differences between patient characteristic groups denoted by: c P , 0.05, d P , 0.01, e P , 0.001
Table 3. Predictors of inadequate adequacy measures
Patient characteristic Odds ratio (95% CI) P value
For weekly Kt/V urea
Male gender 2.5 (1.5, 4.0) ,0.001
Duration of dialysis years (referent 5 ,1)
1–2 years 1.5 (0.82, 2.7) 0.1949
21 years 2.1 (1.2, 3.5) ,0.01
BSA quartile (referent 5 lowest quartile)
,25th–50th percentile 2.6 (1.3, 5.1) ,0.01
50th–75th percentile 1.6 (0.80, 3.2) 0.1891
.75th percentile 3.4 (1.7, 6.9) ,0.001
For weekly creatinine clearance
Female gender 2.8 (1.6, 4.6) ,0.001
Duration of dialysis years (referent 5 ,1)
1–2 years 1.7 (0.95, 3.1) 0.0740
21 years 4.2 (2.5, 7.1) ,0.001
BSA quartile (referent 5 lowest quartile)
,25th–50th percentile 2.6 (1.3, 5.1) ,0.01
50th–75th percentile 1.8 (0.90, 3.6) 0.0974
.75th percentile 3.3 (1.6, 6.9) ,0.01
dialysis as measured by creatinine clearance is probably this six-month period in approximately one quarter of
the PD cycler cohort, and it is possible that these patientsa result of mathematical artifact. For a given BSA, men
have a higher volume than women; conversely, for a given were at higher risk of receiving inadequate dialysis, as
there were no adequacy data available to adjust thesevolume, women have a higher BSA than men [16, 17].
We were unable to assess the adequacy of dialysis in patients’ prescriptions. Our data are not directly compa-
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Fig. 5. Relationship between prescribed daily dialysate vol-
ume, body surface area, and duration of dialysis.
ing importance in the last three years, coincident with
the development of new, compact cycler machines by
several different dialysis equipment manufacturers. Both
the U.S. Renal Data System and our PD-CIS surveys
have documented a significant increase in the percentage
of patients who use the cycler modality of PD, with a
corresponding decline in the percentage of patients using
CAPD [2]. There are also significant regional variations
in the use of PD cycler therapy among the 18 ESRD
networks (data not shown), and the rationale for these
national and regional differences is not well understood.
With the exception of a slightly lower African American
enrollment into cycler therapy, this survey did not iden-
tify a major difference in reported patient characteristics
to explain assignment to CAPD or cycler therapy. Clearly,
neither age, gender, weight, primary diagnosis, nor peri-
Fig. 6. Distribution of nighttime ( ) and daytime ( ) dwell volumes toneal equilibrium test (PET) membrane characteristics
in the 1997 PD cycler cohort.
are the primary determinants of modality selection among
adult PD patients. A physiologic rationale for the choice
of a specific PD modality is based on the analysis of
peritoneal membrane transport characteristics. Patientsrable to the USRDS Dialysis Morbidity and Mortality
defined as “high or rapid transporters” are presumablyWave 2 data, as the U.S. Renal Data System study re-
candidates for cycler therapy because they can achievecorded PD prescriptions in only incident patients at ap-
high clearances with short dwell times of less than threeproximately day 60 of chronic dialysis therapy [2].
hours, whereas those with “slow or low permeability”Because PD cycler therapy is more costly, requires a
membranes should use CAPD [26–29] because theymechanical device in the home, and uses more dialysate
more readily achieve higher clearances with dwell timesthan CAPD [18, 19], it had traditionally been reserved
of five to eight hours. In our PD-CIS survey, however,for the management of dependent patients who require
the average dialysate to plasma ratio for creatinine fromdialysis assistance, “high transport” patients, and chil-
the PET was 0.68 in both CAPD and cycler patients.dren [18, 20]. More recent reports have indicated that
Finally, social factors may be the major determinant incycler therapy, compared with CAPD therapy, results in
choosing cycler therapy [25, 28], and ultimately, bothreduced peritonitis risk [18, 19, 21–23], better compliance
cost and reimbursement impact this choice [19, 28].with the PD prescription [24], and higher patient prefer-
ence [25]. The use of cycler therapy has taken on increas- The patient subgroup at the highest risk for less than
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Table 4. Mean dwell volumes by BSA and duration of dialysis
Mean nighttime dwell volume (ml 6 sd) Mean daytime dwell volume (ml 6 sd)
Duration of dialysis Duration of dialysis
BSA quartile ,1 yearb 1–2 yearsb .2 yearsb ,1 yearb 1–2 yearsa .2 yearsb
,25th 1987 (6306) 2092 (6262) 1964 (6327) 1736 (6520) 1612 (6591) 1720 (6457)
25th–50th 2186 (6439) 2049 (6298) 2234 (6359) 1822 (6454) 1788 (6415) 1872 (6481)
50th–75th 2173 (6282)c 2259 (6353) 2346 (6300) 1796 (6472)d 1938 (6336) 2171 (6330)
.75th 2322 (6317) 2509 (6469) 2383 (6357) 2171 (6409) 2156 (6434) 2177 (6553)
By duration of dialysis, statistically significant differences among quartiles of BSA: a P , 0.05, b P , 0.001
By quartile at BSA, statistically significant differences among duration of dialysis categories: c P , 0.05 for nighttime; d P , 0.01 for daytime
Fig. 8. Distribution of the number of nighttime ( ) and daytime ( )Fig. 7. Distribution of nighttime dwell times in the 1997 PD cycler
exchanges in the 1997 PD cycler cohort.cohort.
tion of the daytime dwell should also be adjusted basedadequate PD was the group that had received PD for
on the patient’s transport characteristics in order to max-more than two years. This increased risk of inadequate
imize the clearance provided with this exchange(s). Pa-dialysis occurred despite the observation that patients
tients who weigh more than 100 kg will almost alwayswith a duration of dialysis greater than two years had a
require both nighttime cycler exchanges as well as two orhigher prescribed 24-hour dialysate volume than patients
more daytime exchanges in order to achieve an adequatewith a shorter duration of dialysis. In cycler patients,
dose of dialysis [31]. It is not known, however, if andialysis dose can be increased by several methods, includ-
intensive dialysis schedule increases the risk of noncom-ing an increase in the dwell volume, the addition of
pliance with the PD prescription and subsequent patientone or more daytime dwells, and the adjustment of the
burnout and transfer to hemodialysis [24].nighttime dwell number and dwell time. An increase in
The adjustment of the PD cycler prescription is morethe dwell volume per exchange is a very effective method
complex than for the CAPD prescription because thefor improving dialysis adequacy. A 500 ml increase in the
optimal time for the duration of a single cycler exchangedwell volume per exchange may improve dialysis ade-
is critically dependent on the patient’s transport charac-quacy by up to 25% [30]. Although it appears that many
teristics. In general, the higher the D/P creatinine ratiodialysis health care providers are reluctant to increase
from the PET, the shorter the optimal dwell time. Indwell volume because of concerns regarding patient dis-
addition, the use of more dialysate volume does notcomfort, Piraino et al have demonstrated that blinded
always lead to an increase in the dose of dialysis [30].patients could not reliably differentiate between 2.0, 2.5,
Several computer software programs developed by bothand 3.0 liter dwells [abstract; Piraino et al, Perit Dial Int
dialysis equipment manufacturers and by independent18(Suppl 1):S22, 1998]. In many cycler patients, the use
companies, as well as nomograms [32, 33], are availableof one or more daytime dwells will significantly increase
and can assist with choosing an initial cycler prescriptionthe dose of dialysis provided. For anephric patients who
and providing an estimate of the expected dose of dial-are not high transporters, virtually all but the smallest
ysis. The use of either the software programs or nomo-sized patients will require at least one daytime dwell in
order to achieve an adequate dose of dialysis. The dura- grams requires information not only about patient size
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